Cancer BiologybioRxivPreprint
The CD58:CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity
P. Ho, J. C. Melms, M. Rogava…·B. Izar
The paper identifies the CD58:CD2 axis as co-regulated with PD-L1 via CMTM6 and shows its role in anti-tumor immunity, proposing therapeutic strategies to enhance immunotherapy.